Business
What defines us is our patient-first philosophy and a very pragmatic approach to drug development.
Hi, what are you looking for?
What defines us is our patient-first philosophy and a very pragmatic approach to drug development.
ALS, which is also known as Lou Gehrig's Disease, is a rare neurological disease that affects motor neurons — the nerve cells.
Data demonstrates halting of disease progression in patients with ALS at 24 weeks.
According to the Center for Disease Control and Prevention, 376,000 cases of reported Lyme disease occur in the U.S. Lyme disease is a bacterial...
Amyotrophic lateral sclerosis commonly referred to as ALS, motor neurone disease, or to Lou Gehrig’s disease. The disease is rare and it acts to...
California-based biotechnology company Genervon has announced results of a Phase 2 clinical trial involving 12 amyotrophic lateral sclerosis (ALS) patients. The experimental drug, called...